Background illustration for clinical trials search

Paid Clinical Trials Toronto

Discover 2,121 paid clinical trials in Toronto, Ontario. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Patient Reported Outcomes/Metrics Program Trial

for
Metastatic Cancer, Palliative
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT04983199

Recruiting

LANDscape MApping of Epitopes and T Cell Receptors for Selected Cancers

for
Solid Tumor
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT04665388

Recruiting

Surveillance of Complex Renal Cysts - The SOCRATIC Study

for
Complex Renal Cyst
Location: Toronto, Hamilton, Woodstock, Ottawa, Montreal,
Sponsor: Université de Sherbrooke

Sex: All

Age: 18+

Code: NCT04558593

Recruiting

Single vs. Multiple Fraction Trial of Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastases/Progression

for
Oligometastatic Disease, Oligoprogression,
Location: Toronto, Greater Sudbury, Kelowna, Prince George,
Sponsor: Robert Olson

Sex: All

Age: 18+

Code: NCT05784428

Recruiting

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

for
Hematologic Malignancies, Waldenstroms Macroglobulinaemia,
Location: Toronto, Ottawa, Montreal, Hackensack NJ,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT04728893

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System

for
Recurrent Prostate Cancer
Location: Toronto, New York NY
Sponsor: SpectraCure AB

Sex: Male

Age: 18+

Code: NCT03067051

Phase 1, Phase 2, Recruiting

A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)

for
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Location: Toronto, Detroit MI, Columbus OH, Baltimore MD,
Sponsor: Nuvalent Inc.

Sex: All

Age: 18+

Code: NCT06521554

Phase 1, Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors, Colorectal Cancer
Location: Toronto, Ann Arbor MI, Grand Rapids MI,
Sponsor: Vividion Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06004245

Phase 1, Recruiting

A Pan-Canadian, Investigator Initiated Clinical Trial With Focal IRE Directed to Intermediate-Risk Prostate Cancer

for
Prostate Cancer
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: Male

Age: 50+

Code: NCT06451445

Recruiting

A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

for
Advanced Non-small Cell Lung Cancer, HER2 Mutation
Location: Toronto, Brampton, Pittsburgh PA, Maumee OH, Montreal,
Sponsor: Bayer

Sex: All

Age: 18+

Code: NCT06452277

Phase 3, Recruiting

MR-Adaptive Radiation Therapy for Anal Cancer With EScalated-Treatment in a Risk-Optimized Approach

for
Anal Squamous Cell Carcinoma
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT06050707

Phase 2, Recruiting

PSMA-Guided Ablation of the Prostate

for
Prostate Cancer, Localized Prostate Carcinoma
Location: Toronto, Edmonton, Calgary
Sponsor: University of Alberta

Sex: Male

Age: 50+

Code: NCT06003556

Phase 2, Recruiting

Evaluation of Technological Innovation in Radiotherapy

for
Cancer, Radiotherapy Side Effect
Location: Toronto, London, Laval, Montreal, Quebec, Kelowna,
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Sex: All

Age: 18+

Code: NCT03378856

Recruiting

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

for
Non-small Cell Lung Cancer, Anaplastic Lymphoma Kinase-positive
Location: Toronto, Sellersville PA, Columbus OH, New York NY,
Sponsor: Nuvalent Inc.

Sex: All

Age: 18+

Code: NCT06765109

Phase 3, Recruiting

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Toronto, Ann Arbor MI, Boston MA, Dallas TX, Houston TX,
Sponsor: LigaChem Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT05941507

Phase 1, Phase 2, Recruiting

Study of Lunresertib Alone or in Combination With RP-3500 or Debio 0123 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Toronto, Grand Rapids MI, New York NY, New Hyde Park NY,
Sponsor: Debiopharm International SA

Sex: All

Age: 12+

Code: NCT04855656

Phase 1, Recruiting

Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration

for
Solid Tumors
Location: Toronto, Philadelphia PA, New York NY, Fairfax VA,
Sponsor: ORIC Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05315700

Phase 1, Phase 2, Recruiting

Moderate Hypofractionated Boost to the Prostate With Pelvic RT in High Risk Prostate Cancer

for
Prostate Cancer
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: Male

Age: 18+

Code: NCT05313815

Recruiting

Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer

for
Biliary Tract Cancer
Location: Toronto, New York NY, Richmond VA, Louisville KY,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06282575

Phase 3, Recruiting

Pan Tumor Rollover Study

for
Cancer
Location: Toronto, Lancaster PA, Columbus OH, Mineola NY,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT03899155

Phase 2, Recruiting